Literature DB >> 23975544

AKR1B10 is induced by hyperglycaemia and lipopolysaccharide in patients with diabetic nephropathy.

Nicholas Shaw1, Bingmei Yang, Ann Millward, Andrew Demaine, Andrea Hodgkinson.   

Abstract

Aldose reductase family member B10 (AKR1B10) belongs to the aldo-keto reductase gene superfamily and is closely related to aldose reductase (AKR1B1). It has been shown that AKR1B10 is present in many of the same human tissues as AKR1B1. The objective of this study was to investigate whether AKR1B10 has a role in diabetic nephropathy (DN) by investigating its response to high glucose and inflammation, both of which have been associated with the development and progression of DN. Expression levels of AKR1B10 were determined in peripheral blood mononuclear cells (PBMCs) obtained from 25 patients with type 1 diabetes and nephropathy, 25 without DN and 25 normal healthy controls that were exposed to high glucose (25 mM D-glucose) and also the inflammatory stressor lipopolysaccharide (LPS, 10 μm). Under high glucose and LPS conditions, there was a significant increase in the expression of AKR1B10 in the PBMCs from patients with DN compared to those without DN and the normal controls. In conclusion, these results suggest that AKR1B10 may have an important role in the development and progression of DN.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23975544      PMCID: PMC3933614          DOI: 10.1007/s12192-013-0455-6

Source DB:  PubMed          Journal:  Cell Stress Chaperones        ISSN: 1355-8145            Impact factor:   3.667


  44 in total

1.  Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

Authors:  Amanda I Adler; Richard J Stevens; Sue E Manley; Rudy W Bilous; Carole A Cull; Rury R Holman
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

2.  Mediation of aldose reductase in lipopolysaccharide-induced inflammatory signals in mouse peritoneal macrophages.

Authors:  Kota V Ramana; Satish K Srivastava
Journal:  Cytokine       Date:  2006-12-15       Impact factor: 3.861

3.  Comparative functional analysis of human medium-chain dehydrogenases, short-chain dehydrogenases/reductases and aldo-keto reductases with retinoids.

Authors:  Oriol Gallego; Olga V Belyaeva; Sergio Porté; F Xavier Ruiz; Anton V Stetsenko; Elena V Shabrova; Natalia V Kostereva; Jaume Farrés; Xavier Parés; Natalia Y Kedishvili
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

4.  Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages.

Authors:  Kota V Ramana; Amin A Fadl; Ravinder Tammali; Aramati B M Reddy; Ashok K Chopra; Satish K Srivastava
Journal:  J Biol Chem       Date:  2006-09-06       Impact factor: 5.157

5.  Aldose reductase expression is induced by hyperglycemia in diabetic nephropathy.

Authors:  A D Hodgkinson; K L Søndergaard; B Yang; D F Cross; B A Millward; A G Demaine
Journal:  Kidney Int       Date:  2001-07       Impact factor: 10.612

6.  Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappaB.

Authors:  S Y Na; B Y Kang; S W Chung; S J Han; X Ma; G Trinchieri; S Y Im; J W Lee; T S Kim
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

7.  Effect of retinoic acid in experimental diabetic nephropathy.

Authors:  Sang-Youb Han; Gyeong-A So; Yi-Hwa Jee; Kum-Hyun Han; Young-Sun Kang; Hyoung-Kyu Kim; Shin-Wook Kang; Dae-Suk Han; Jee-Young Han; Dae-Ryong Cha
Journal:  Immunol Cell Biol       Date:  2004-12       Impact factor: 5.126

8.  Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats.

Authors:  C Sassy-Prigent; D Heudes; C Mandet; M F Bélair; O Michel; B Perdereau; J Bariéty; P Bruneval
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

9.  Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation.

Authors:  Irfan Rahman; Peter S Gilmour; Luis Albert Jimenez; William MacNee
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

10.  Aldo-keto reductases from the AKR1B subfamily: retinoid specificity and control of cellular retinoic acid levels.

Authors:  F Xavier Ruiz; Oriol Gallego; Albert Ardèvol; Armando Moro; Marta Domínguez; Susana Alvarez; Rosana Alvarez; Angel R de Lera; Carme Rovira; Ignacio Fita; Xavier Parés; Jaume Farrés
Journal:  Chem Biol Interact       Date:  2008-10-25       Impact factor: 5.192

View more
  12 in total

Review 1.  AKR1B1 Upregulation Contributes to Neuroinflammation and Astrocytes Proliferation by Regulating the Energy Metabolism in Rat Spinal Cord Injury.

Authors:  Xiaoqing Chen; Cheng Chen; Jie Hao; Rongqing Qin; Baiyu Qian; Kai Yang; Jiyun Zhang; Feng Zhang
Journal:  Neurochem Res       Date:  2018-06-12       Impact factor: 3.996

2.  Copy-number variation associated with congenital anomalies of the kidney and urinary tract.

Authors:  Georgina Caruana; Milagros N Wong; Amanda Walker; Yves Heloury; Nathalie Webb; Lilian Johnstone; Paul A James; Trent Burgess; John F Bertram
Journal:  Pediatr Nephrol       Date:  2014-10-01       Impact factor: 3.714

3.  Uncovering genetic mechanisms of hypertension through multi-omic analysis of the kidney.

Authors:  James M Eales; Xiao Jiang; Xiaoguang Xu; Sushant Saluja; Artur Akbarov; Eddie Cano-Gamez; Michelle T McNulty; Christopher Finan; Hui Guo; Wojciech Wystrychowski; Monika Szulinska; Huw B Thomas; Sanjeev Pramanik; Sandesh Chopade; Priscilla R Prestes; Ingrid Wise; Evangelos Evangelou; Mahan Salehi; Yusif Shakanti; Mikael Ekholm; Matthew Denniff; Alicja Nazgiewicz; Felix Eichinger; Bradley Godfrey; Andrzej Antczak; Maciej Glyda; Robert Król; Stephen Eyre; Jason Brown; Carlo Berzuini; John Bowes; Mark Caulfield; Ewa Zukowska-Szczechowska; Joanna Zywiec; Pawel Bogdanski; Matthias Kretzler; Adrian S Woolf; David Talavera; Bernard Keavney; Pasquale Maffia; Tomasz J Guzik; Raymond T O'Keefe; Gosia Trynka; Nilesh J Samani; Aroon Hingorani; Matthew G Sampson; Andrew P Morris; Fadi J Charchar; Maciej Tomaszewski
Journal:  Nat Genet       Date:  2021-05-06       Impact factor: 41.307

4.  Transcriptomic alterations in the heart of non-obese type 2 diabetic Goto-Kakizaki rats.

Authors:  Márta Sárközy; Gergő Szűcs; Veronika Fekete; Márton Pipicz; Katalin Éder; Renáta Gáspár; Andrea Sója; Judit Pipis; Péter Ferdinandy; Csaba Csonka; Tamás Csont
Journal:  Cardiovasc Diabetol       Date:  2016-08-05       Impact factor: 9.951

5.  Loss of AKR1B10 promotes colorectal cancer cells proliferation and migration via regulating FGF1-dependent pathway.

Authors:  Yizhou Yao; Xuchao Wang; Diyuan Zhou; Hao Li; Huan Qian; Jiawen Zhang; Linhua Jiang; Bin Wang; Qi Lin; Xinguo Zhu
Journal:  Aging (Albany NY)       Date:  2020-07-02       Impact factor: 5.682

6.  Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction.

Authors:  Cleverson T Soares; Luciana R V Fachin; Ana P F Trombone; Patricia S Rosa; Cássio C Ghidella; Andrea F F Belone
Journal:  Front Med (Lausanne)       Date:  2018-09-24

7.  Exploring the Molecular Mechanism of Liuwei Dihuang Pills for Treating Diabetic Nephropathy by Combined Network Pharmacology and Molecular Docking.

Authors:  Gaoxiang Wang; Lin Zeng; Qian Huang; Zhaoqi Lu; Ruiqing Sui; Deliang Liu; Hua Zeng; Xuemei Liu; Shufang Chu; Xinhui Kou; Huilin Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-13       Impact factor: 2.629

8.  Three dimensional modeling of biologically relevant fluid shear stress in human renal tubule cells mimics in vivo transcriptional profiles.

Authors:  Emily J Ross; Emily R Gordon; Hanna Sothers; Roshan Darji; Oakley Baron; Dustin Haithcock; Balabhaskar Prabhakarpandian; Kapil Pant; Richard M Myers; Sara J Cooper; Nancy J Cox
Journal:  Sci Rep       Date:  2021-07-07       Impact factor: 4.379

Review 9.  The Role of AKR1B10 in Physiology and Pathophysiology.

Authors:  Satoshi Endo; Toshiyuki Matsunaga; Toru Nishinaka
Journal:  Metabolites       Date:  2021-05-21

10.  Expression of aldo-keto reductase family 1 member b10 in the early stages of human hepatocarcinogenesis.

Authors:  Hironori Tsuzura; Takuya Genda; Shunsuke Sato; Ayato Murata; Yoshio Kanemitsu; Yutaka Narita; Sachiko Ishikawa; Tetsu Kikuchi; Masashi Mori; Katsuharu Hirano; Katsuyori Iijima; Ryo Wada; Takafumi Ichida
Journal:  Int J Mol Sci       Date:  2014-04-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.